1h Free Analyst Time
The publisher has been monitoring the rheumatoid arthritis diagnostic devices market and it is poised to grow by $ 146.54 mn during 2022-2026, accelerating at a CAGR of 5.55% during the forecast period. Our report on the rheumatoid arthritis diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increasing number of rheumatoid arthritis cases, availability of improved diagnostic modalities, and lucrative opportunities in emerging economies.
The rheumatoid arthritis diagnostic devices market analysis includes product segment and geographic landscape.
The publisher's rheumatoid arthritis diagnostic devices market is segmented as below:
By Product
- Analyzers
- Consumables
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing number of business strategies as one of the prime reasons driving the rheumatoid arthritis diagnostic devices market growth during the next few years. Also, the growing focus on biomarkers and precision medicine and funding for clinical studies on rheumatoid arthritis will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the rheumatoid arthritis diagnostic devices market covers the following areas:
- Rheumatoid arthritis diagnostic devices market sizing
- Rheumatoid arthritis diagnostic devices market forecast
- Rheumatoid arthritis diagnostic devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rheumatoid arthritis diagnostic devices market vendors that include Abbott Laboratories, Antibodies Inc., Augurex Life Sciences Corp., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Danaher Corp., DNAlytics SA, Eurobio Scientific, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the rheumatoid arthritis diagnostic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Exhibits:
Executive Summary
The publisher recognizes the following companies as the key players in the global rheumatoid arthritis diagnostic devices market: Abbott Laboratories, Antibodies Inc., Augurex Life Sciences Corp., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Danaher Corp., DNAlytics SA, Eurobio Scientific, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA.Commenting on the report, an analyst from the publisher said: "The latest trend gaining momentum in the market is growing number of business strategies."
According to the report, one of the major drivers for this market is the increasing number of rheumatoid arthritis cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Antibodies Inc.
- Augurex Life Sciences Corp.
- Aviva Systems Biology Corp.
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Dnalytics Sa
- Eurobio Scientific
- F. Hoffmann La Roche Ltd.
- Myriad Genetics Inc.
- Qiagen Nv
- Quest Diagnostics Inc.
- Siemens AG
- Svar Life Science Ab
- Thermo Fisher Scientific Inc.
- Werfenlife Sa
